Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $119

Author: Benzinga Newsdesk | May 09, 2024 12:17pm
TD Cowen analyst Ryan Langston maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $105 to $119.

Posted In: ADUS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist